The response to the angiotensin antagonist saralasin in predicting therapeutic outcome in hypertension treated with frusemide

Eur J Clin Pharmacol. 1981;21(3):165-8. doi: 10.1007/BF00627914.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiotensin II / analogs & derivatives*
  • Blood Pressure
  • Diet, Sodium-Restricted
  • Female
  • Follow-Up Studies
  • Furosemide / therapeutic use*
  • Humans
  • Hypertension / diet therapy
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Male
  • Middle Aged
  • Renin / blood
  • Retrospective Studies
  • Saralasin*

Substances

  • Angiotensin II
  • Furosemide
  • Renin
  • Saralasin